...
首页> 外文期刊>BMC Complementary and Alternative Medicine >Anti-diabetic potential of Catharanthus roseus Linn. and its effect on the glucose transport gene (GLUT-2 and GLUT-4) in streptozotocin induced diabetic wistar rats
【24h】

Anti-diabetic potential of Catharanthus roseus Linn. and its effect on the glucose transport gene (GLUT-2 and GLUT-4) in streptozotocin induced diabetic wistar rats

机译:长春花的抗糖尿病潜力。及其对链脲佐菌素致糖尿病wistar大鼠葡萄糖转运基因(GLUT-2和GLUT-4)的影响

获取原文
           

摘要

Background Catharanthus roseus is an important Ayurvedic medication in traditional medicine. It is potentially used in countries like India, South Africa, China and Malaysia for the healing of diabetes mellitus. Although, the molecular mechanisms behind this effect are yet to be exclusively explored. Due to the great antidiabetic and hyperlipidemic potential of c. roseus, we hypothesized that the insulin mimetic effect of ethanolic extract of c. roseus might add to glucose uptake through improvement in the expression of genes of the glucose transporter (GLUT) family messenger RNA (mRNA) in liver. Methods STZ-induced diabetic rats treated by ethanolic extract of c. roseus 100 mg/kg and 200 mg/kg; and one group treated with Metformin (100 mg/kg). After final administration of treatment of 4 weeks, blood samples were collected under fasting conditions, and the body weights (BWs) were measured. Total RNA from liver was extracted with the Qiagen RNEasy Micro kit (GERMANY) as described in the manufacturer’s instructions. First-strand complementary DNA (cDNA) was synthesized at 40 °C by priming with oligo-dT12–18 (Invitrogen, USA) and using Super ScriptII reverse transcriptase according to the protocol provided by the manufacturer (Invitrogen, USA). Real-time polymerase chain reaction (PCR) amplifications for GLUT-4 (gene ID: 25139) were conducted using Light-Cycler 480 (Roche, USA) with the SyBr? I nucleic acid stain (Invitrogen, USA) according to the manufacturer's instructions. Polymerase chain reaction products of β-actin primer gene were used as an internal standard. Results The proposed study was framed to look at the antidiabetic efficacy of ethanolic extract of c. roseus and an expression of GLUT-2 and GLUT-4 gene in streptozotocin induced diabetic wistar rats. The doses were administered orally at a rate of 100 and 200?mg/kg and detrain the glucose transport system in liver for 4?weeks. The observed results showed a good positive correlation between intracellular calcium and insulin release levels in isolated islets of Langerhans. The supplementation of ethanolic extract of c. roseus significantly amplified the expression of GLUT gene mRNA by Real Time PCR in liver of diabetic rats. Conclusions We conclude that the observed antidiabetic effect of c. roseus on STZ induced diabetes was a result of complex mechanisms of GLUT gene mRNA expression. The findings are very encouraging and greatly advocate its candidature for the design of a novel herbal drug to cure deadly diabetes.
机译:背景长春花是传统医学中一种重要的印度草药疗法。它可能在印度,南非,中国和马来西亚等国家用于治愈糖尿病。虽然,这种作用背后的分子机制尚待专门研究。由于c的巨大的抗糖尿病和高血脂的潜力。玫瑰,我们假设c的乙醇提取物的胰岛素模拟作用。玫瑰可能通过改善肝脏中葡萄糖转运蛋白(GLUT)家族信使RNA(mRNA)的基因表达来增加葡萄糖的摄取。方法采用乙醇提取物对STZ诱导的糖尿病大鼠进行治疗。玫瑰100 mg / kg和200 mg / kg;一组用二甲双胍(100 mg / kg)治疗。最终给予4周治疗后,在禁食条件下采集血液样本,并测量体重(BW)。按照制造商的说明,使用Qiagen RNEasy Micro试剂盒(德国)提取肝脏中的总RNA。第一链互补DNA(cDNA)通过在40°C下用oligo-dT12-18(美国Invitrogen公司)引物引发,并根据制造商(美国Invitrogen公司)提供的规程使用Super ScriptII逆转录酶进行合成。使用Light-Cycler 480(Roche,USA)和SyBr?进行GLUT-4(基因ID:25139)的实时聚合酶链反应(PCR)扩增。 I核酸染色剂(Invitrogen,美国)根据制造商的说明。 β-肌动蛋白引物基因的聚合酶链反应产物用作内标。结果拟定的研究旨在观察c的乙醇提取物的抗糖尿病功效。链脲佐菌素诱导的糖尿病wistar大鼠体内玫瑰红花和GLUT-2和GLUT-4基因的表达。口服剂量为100和200?mg / kg,使肝脏中的葡萄糖转运系统失调4周。观察到的结果表明,朗格汉斯分离岛中的细胞内钙和胰岛素释放水平之间存在良好的正相关。 c。乙醇提取物的补充。实时荧光定量PCR法检测玫瑰鼠糖尿病大鼠肝脏中GLUT基因mRNA的表达。结论我们得出的结论是c的抗糖尿病作用。玫瑰对STZ诱导的糖尿病的作用是GLUT基因mRNA表达复杂机制的结果。该发现非常令人鼓舞,并极大地鼓吹了其作为候选药来治疗致命性糖尿病的候选资格。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号